Therapeutic inhibition of SGK1 suppresses colorectal cancer

Colorectal cancer (CRC) is one of the leading causes of death worldwide. Thus, the development of new therapeutic targets for CRC treatment is urgently needed. SGK1 is involved in various cellular activities, and its dysregulation can result in multiple cancers. However, little is known about its ro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Exp Mol Med
Autors principals: Liang, Xuchun, Lan, Chunling, Jiao, Guanming, Fu, Wencheng, Long, Xuesha, An, Yu, Wang, Kejin, Zhou, Jinzhe, Chen, Ting, Li, Yongqin, Xu, Jiahong, Huang, Qi, Xu, Bin, Xiao, Junjie
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5704191/
https://ncbi.nlm.nih.gov/pubmed/29170478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2017.184
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars